Search Results

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc . (“Bioness”), a global leader in neuromodulation and rehabilitation medical devices through its innovative peripheral nerve stimulation (“PNS”) therapy and premium rehabilitation solutions, for $45 million in up-front consideration, with up to $65 million of contingent consideration

Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced the commercial launch of the new Bioness Integrated Therapy System (BITS) for Balance.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the first commercial shipments of the Bioness Integrated Therapy System (BITS) for Balance.

Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, today announced its attendance at the 2020 North American Neuromodulation Society’s Annual Meeting (NANS) in Las Vegas, Nevada, January 23-26, 2020